Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. [electronic resource]
Producer: 20090106Description: 5761-6 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Boston
- Carboplatin -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Fallopian Tube Neoplasms -- drug therapy
- Female
- Glutamates -- administration & dosage
- Guanine -- administration & dosage
- Humans
- Infusions, Intravenous
- Kaplan-Meier Estimate
- Middle Aged
- Neoplasm Recurrence, Local
- Ovarian Neoplasms -- drug therapy
- Pemetrexed
- Peritoneal Neoplasms -- drug therapy
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.